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Abstract 
a,-Macroglobuhn receptor/low density hpoprotem receptor-related protein (cc,M-RILRP) IS a multi-functional cell-surface receptor that has been 
tmphcated m diverse physiologic processes In normal human brain, a,M-R/LRP IS expressed prmclpally by pyramldal neurons with locahzation 
to cell bodies and proximal processes By contrast, a,M-R/LRP 1s not present m either the cell bodies or processes of most normal macrogha (mcludmg 
astrocytes) In this mvestlgatlon, we studied the expression of a,M-FULRP m the brain, followmg tissue InJury or neoplastic transformation, by 
lmmunohistochemlstry Significantly increased a,M-R/LRP lmmunoreactivlty was ldentlfied m reactive astrocytes, mdlcatmg that expression of this 
receptor is regulated m viva m response to brain injury a2M-R/LRP lmmunoreactivlty was also detected m ghal cell tumors. this finding 1s novel 
since malignant ransformation 1s typically thought to turn off expression of this receptor 
Key words a*-Macroglobulm receptor, Low density hpoprotem receptor-related protem, Tumor mvaslon, Ghoma 
1. Introduction 
ol,-Macroglobuhn receptor/low-density hpoprotem re- 
ceptor-related protem (a,M-RILRP) 1s a multl-func- 
tlonal plasma membrane receptor which has been lmph- 
cated m cellular hpoprotem metabolism, cell-surface 
trafficking of plasmmogen activators and then mhlb- 
ltors, modulation of growth factor responses, and Pseu- 
domonas exotoxm A clearance [l-6] a,M-RILRP 1s syn- 
thesized as a 600 kDa precursor protein which undergoes 
post-translational processing mto 5 15-kDa and 85-kDa 
subunits [7,8]. The 5 15-kDa subunit confers hgand bmd- 
mg activity and 1s entirely extracellular The 85-kDa sub- 
unit has a transmembrane domam that anchors the large 
subunit to the cell surface by a non-covalent interaction 
[8,9] a,M-RILRP and Its mRNA are distributed 
through numerous human tissues [7,10], however, the 
cellular distribution m human brain 1s selective Im- 
munoreactlvlty 1s restricted almost exclusively to neu- 
rons, prmclpally of the pyramidal type m the cerebral 
cortex, subcortlcal gray matter, and cerebellum [lO,l 1] 
Although a,M-RILRP 1s not normally expressed by 
most gha, lmmunoreactlvlty is detected m a highly local- 
ized perlvascular zone which corresponds to the dlstnbu- 
tlon of astrocytic foot processes. Expression of a,M-RI 
LRP m this region suggests a role for the receptor m the 
function of the blood-brain barrier 
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Expression of a,M-RILRP IS regulated m vitro by 
cytokmes and mediators of mflammatlon In macro- 
phages, cx,M-R/LRP 1s up-regulated by colony stlmulat- 
mg factor-l and down-regulated by interferon-y and 
bacterial hpopolysaccharlde [ 12,131 Based on work with 
fibroblasts m culture, Van Leuven et al [14] suggested 
that cancer cells may express greatly decreased levels of 
a,M- R/LRP. More recently, we demonstrated that &,M- 
R/ LRP 1s decreased or absent m hepatocellular carcmo- 
mas, as determined by lmmunohlstochemlstry [15] 
Followmg brain injury or after neoplastlc transforma- 
tion, astrocytes undergo profound phenotyplc changes, 
associated with increased prohferatlon and an aug- 
mented capacity for tissue mvaslon The purpose of the 
present mvestlgatlon was to determine whether brain 
qury or ghal neoplastlc transformation 1s associated 
with altered ol,M-R/LRP expression 
2. Materials and methods 
2 I Materials 
Fifty-seven ghoma specimens from archives of the Umverslty of 
Virgmla Health Sciences Center were exammed The tumors were clas- 
sified accordmg to the World Health Orgamzatlon (WHO) crltena [16] 
Hlstopathological exammatlon revealed 4 low-grade astrocytomas, 2
gemlstocytic astrocytomas, 11 anaplastic astrocytomas, I3 ghoblasto- 
mas multiforme, 2 gliosarcomas, 13 pilocytic astrocytomas, 1pleomor- 
phic xanthoastrocytoma, 1 optic ghoma, 3 ohgodendroghomas, and 7 
ependymomas Reactive (non-neoplastic) astrocytes were studied m 5 
specimens with acute and chronic infarcts and m the tissue adjacent o 
tumors 
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2 2 Immunohutochemzstry 
Monoclonal antlbody 8Gl dlrected against he a,M-R/LRP SlS-kDa 
cham was kmdly provided by Dr Dudley K Stnckland (Amencan Red 
Cross, Rockvdle, MD) 8Gl was incubated with formahn-fixed, de- 
paraffimzed sectlons for 15-18 h at 4°C The primary antibody was 
detected usmg the avldm-blotm lmmunoperoxldase technique [l l] 
Normal non-immune serum was substituted for primary antibody as 
a negative control Sections of normal human liver were treated m 
parallel to provide positive controls 
3. Results and discussion 
In contrast with quiescent astrocytes m normal brain, 
activated astrocytes m the gray and white matter were 
consistently mrmunoreactive for a,M-RILRP The pat- 
tern of immunoreactivity varied from predommantly 
permuclear, punctate accumulations, to a more diffuse 
cytoplasmic distribution The first pattern (Fig 1, arrow- 
heads) was highly suggestive of an mtracytoplasmic dis- 
tribution while the diffuse form (Fig 1, inset) could re- 
flect a combmation of both surface and cytoplasmic lo- 
calization The cytoarchitectural distribution of a,M-RI 
LRP m reactive astrocytes was clearly different from the 
restricted pattern of mmmnoreactivity m perivascular 
astrocytic processes, reported previously [l 11. Activated 
astrocytes were the only reactive ghal cells with increased 
a,M-R/LRP Myelm-forming ohgodendrocytes and 
ependymal cells, which lined the ventricles m zones con- 
tiguous with injured brain, did not show a,M-RILRP 
immunoreactivity. 
Neoplastic transformation of macroghal cells resulted 
m increased expression of a,M-RILRP antigen, irre- 
gardless of cell type (ie astrocytic, ohgodendroghal or 
ependymal) (Table 1); however, the level and cy- 
toarchitectural distribution of a,M-RILRP m the differ- 
ent tumors was variable (Table 2). Astrocytomas which 
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Table 1 
a,M-R/LRP lmmunohlstochemlstrv m ghomas 
Tumor Cases (positive/total) 
Astrocytoma 414 
Gemistocytic astrocytoma 212 
Anaplastlc astrocytoma 11111 
Ghoblastoma multlforme 12113 
Pleomorphlc xanthoastrocytoma l/l 
Pllocytic astrocytoma 12113 
Optic ghoma l/l 
Ohgodendroghoma 313 
Ependymoma Ill 
diffusely invade surrounding brain are shown m Fig 
2A-C In many of the tumor cells, a,M-RILRP im- 
munoreactivity was conspicuously localized m the cyto- 
plasm as punctate, permuclear accumulations (panels A 
and C). Other tumor cells with larger amounts of cyto- 
plasm showed more diffuse mununoreactivity (Fig 2B 
and 2C inset) In contrast to the invasive astrocytomas, 
pilocytic astrocytomas, which have limited capacity to 
invade, expressed a,M-RILRP primarily m cell processes 
(Fig 2D) 
Most neoplastic ohgodendroghal cells (Fig 3) and 
ependymal cells (not shown) expressed a,M-RILRP, m 
contrast with then non-malignant (normal and reactive) 
counterparts, which were nnmunonegative The pattern 
of mmmnoreactivity m the ohgodendroghomas varied 
Most cells expressed a,M-R/LRP m a punctate, permu- 
clear pattern, similar to that observed with reactive and 
neoplastic astrocytes (panel A) Other cells demonstrated 
a,M-RILRP nnmunopositivity m a more diffuse pattern 
(panel B); however, this distribution was not common 
The results reported m this mvestigation provide sharp 
Fig 1 Locahzatlon of a,M-R/LRP m a brain infarct Reactive astrocytes on the penphery of the lesion (left) demonstrated cytoplasmlc a,M-RILRP 
lmmunoreactlvity mboth a punctate (small astrocytes, arrowheads) and diffuse (inset gemlstocytlc astrocytes, upper, and fibnllary astrocyte, arrow) 
pattern Fibnllary astrocytes with promment stammg m cellular processes were present m small numbers (inset, arrow) [Monoclonal antibody 8Gl 
lmmunoperoxldase, DAB with light hematoxyhn counterstam, x 300, x 600 mset ] 
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Table 2 
Pattern of a,M-R/LRP lmmunoreactlvlty m ghal cells 
Cytoplasmlc dlstnbutlon 
Reactive astrocytes punctate (clrcumscnbed) > diffuse 
Neoplastlc macrogha punctate (arcumscnbed) > diffuse 
Cellular processes 
Reactive astrocytes rare 
Infiltrating astrocytomas rare 












contrast with our previous study of normal human brain 
[l l] Expression of a,M-R/LRP m reactive and trans- 
formed astrocytes suggests that these cells synthesize 
a,M-R/LRP in response to physrologrc signals in VIVO. 
The predominant mtracytoplasmtc localization of a,M- 
R/LRP in reactive and neoplastic macrogha was surpris- 
mg since a,M-R/LRP is a plasma membrane receptor. 
Moestrup et al. [17] reported a stmtlar finding in their 
analysts of fibroblasts and attributed the mtracytoplas- 
mic distrrbutton of a,M-R/LRP to intracellular vesicles 
m the receptor recycling pathway. 
The function of a,M-R/LRP in normal brain is stall 
unknown, however, protemases, proteinase inhibitors 
and cytokmes are important effecters of ghal-neuronal 
cell interactions. Based on its ability to bmd diverse h- 
gands (some of which are carriers of other macromole- 
Fig 2 Locahzatlon of &M-R/L.RP m astrocytlc tumors (A-C) &M-R/LRP nnmunoreactlvlty was detected m all grades of diffusely mfiltratmg 
astrocytomas (A) a,M-RILRP lmmunoreactlvlty m low-grade astrocytomas was locahzed m the cytoplasm as pun&ate stammg (arrowheads) m the 
pennuclear egon (x 600) (B) Tumor cells with increased cytoplasmlc SW. (gemlstoqtlc astrocytes) usually had a more diffuse pattern of stammg 
Note that the fine fibnllary processes (arrowheads) of the tumor cells are not labelled (x 600) (C)Cells m ghoblastoma multlforme also demonstrated 
a punctate pattern of lmmunostammg for a,M-R/LRP (arrowheads) while the mcreased cytoplasm of @ant, multmucleated cells was more diffusely 
lmmunoreactive (X 300, x 600 Inset) (D) Pllocytlc astrocytomas demonstrated a stnkmg difference of &,M-R/LRP dlstnbutlon, m contrast to the 
diffusely mvaslve astrocytlc tumors, with lmmunoreactlvlty locahzed only to cell processes Note the fine particulate pattern of the stammg m the 
cellular processes (x 600) (Monoclonal antibody 8Gl lmmunoperoxldase, DAB Hrlth hematoxyhn counterstam) 
Fig 3 Locahzatlon of a,M-RILRP m ohgodendroghomas (A) a,M-RI 
LRP lmmunoreactlvlty was conspicuously localized as punctate, per- 
muclear accumulations m the scant cytoplasm (B) In focal areas of the 
same tumor, blunt cellular processes and plasma membrane were also 
hlghhghted by the lmmunostdmmg (x 600) (8Gl lmmunoperoxldase ) 
cules), a,M-RILRP may function m the transfer of critl- 
cal effecters between cells m the bram For example, 
cytokmes, such as transforming growth factor-/?1 (TGF- 
/?l) and platelet-derived growth factor (PDGF), bmd to 
activated azM which 1s a hgand for a,M-RILRP Since 
cytokme bmdmg does not mhlblt the mteractlon of a,M 
with its receptor, these complexes can be targeted to cells 
which express a,M-RILRP [5,18] In the brain, PDGF 1s 
important m ghogenesls [ 191 PDGF also supports prohf- 
eratlon of reactive astrocytes followmg brain mJury [20] 
PDGF and TGF-B mfluence the growth of malignant 
ghomas [21,22] Smce a,M IS present m developmg brain 
[23] and m adult bram durmg subacute responses to 
mlury and chronic degenerative states [24,25], a,M may 
influence the traffickmg of TGF-P and PDGF between 
cells m the brain The ultimate delivery of a,M-TGF-j? 
or a,M-PDGF complex to a particular bram cell de- 
pends on expression of a,M-RILRP Disease processes 
which increase a,M-RILRP expression m ghal cells 
might facilitate ol,M-targetmg of TGF-/3 and PDGF to 
these cells 
Bmdmg of hgands to cx,M-RILRP results m receptor 
clustering m clathrm-coated pits and rapid clearance of 
the receptor-hgand complexes from the cell surface by 
endocytosls [26] The hgands are transferred to lyso- 
somes while the a,M-RILRP typically recycles to the cell 
surface [27] Although all types of ghomas exhlblted 
a,M-RILRP immunoreactlvlty, the more mvaslve astro- 
cytomas demonstrated apredommantly cytoplasmlc pat- 
tern of a,M-R/LRP stammg while the less mvaslve pllo- 
cytlc astrocytomas expressed a,M-RILRP primarily m 
cell processes Pllocytlc astrocytomas express high levels 
of protemase mhlbltors compared with other ghal cell 
neoplasms [28] Whether expression of protemase mhlb- 
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ltors and a,M-RILRP supports the non-mvaslve pheno- 
type of the pllocytlc astrocytoma 1s a topic for future 
investigation 
In summary, the present study has demonstrated that 
expression of a,M-RILRP is regulated m ghal cells m 
vlvo Regulated expression and selective cellular locah- 
zatlon of a,M-RILRP m reactive and neoplastlc gha sug- 
gests a role for this receptor m ghal cell function 
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